Therapeutic response of metastatic colorectal cancer harboring a KRAS missense mutation after combination chemotherapy with the EGFR inhibitor panitumumab

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Therapeutic response of metastatic colorectal cancer harboring a KRAS missense mutation after combination chemotherapy with the EGFR inhibitor panitumumab'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience